Robert Andrade, the Chief Financial Officer of Fennec Pharmaceuticals Inc (NASDAQ:FENC), has sold 30,000 shares of the company on January 5, 2024, according to a recent SEC Filing.
Related Keywords
, Fennec Pharmaceuticals Inc , Iopharmaceutical Company , Nsider Transaction , Nsider Transactions , Insider Sales ,
comparemela.com © 2020. All Rights Reserved.